• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚丙烯腈作为有潜力的抗高血糖药物:合成、α-葡萄糖苷酶抑制活性和分子对接研究。

Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.

机构信息

H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.

H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; Institute of Marine Biotechnology, Universiti Malaysia Terengannu, 21030 Kuala Terengganu, Terengganu, Malaysia.

出版信息

Bioorg Med Chem. 2020 Nov 1;28(21):115605. doi: 10.1016/j.bmc.2020.115605. Epub 2020 Aug 15.

DOI:10.1016/j.bmc.2020.115605
PMID:33065441
Abstract

One of the most prevailing metabolic disorder diabetes mellitus has become the global health issue that has to be addressed and cured. Different marketed drugs have been made available for the treatment of diabetes but there is still a need of introducing new therapeutic agents that are economical and have lesser or no side effects. The current study deals with the synthesis of indole acrylonitriles (3-23) and the evaluation of these compounds for their potential for α-glucosidase inhibition. The structures of these synthetic molecules were deduced by using different spectroscopic techniques. Acarbose (IC = 2.91 ± 0.02 μM) was used as standard in this study and the synthetic molecules (3-23) have shown promising α-glucosidase inhibitory activity. Compounds 4, 8, 10, 11, 14, 18, and 21 displayed superior inhibition of α-glucosidase enzyme in the range of (IC = 0.53 ± 0.01-1.36 ± 0.04 μM) as compared to the standard acarbose. Compound 10 (IC = 0.53 ± 0.01 μM) was the most effective inhibitor of this library and displayed many folds enhanced activity in contrast to the standard. Molecular docking of synthetic compounds was performed to verify the binding interactions of ligand with the active site of enzyme. This study had identified a number of potential α-glucosidase inhibitors that can be used for further research to identify a potent therapeutic agent against diabetes.

摘要

糖尿病是一种流行的代谢紊乱疾病,已成为全球健康问题,必须加以解决和治疗。已经有不同的市售药物可用于治疗糖尿病,但仍需要引入新的治疗剂,这些治疗剂既经济实惠,又副作用较小或没有副作用。本研究涉及吲哚丙烯腈(3-23)的合成及其对α-葡萄糖苷酶抑制潜力的评估。这些合成分子的结构是通过使用不同的光谱技术推导出来的。阿卡波糖(IC = 2.91 ± 0.02 μM)在本研究中用作标准,合成分子(3-23)显示出有希望的α-葡萄糖苷酶抑制活性。与标准阿卡波糖相比,化合物 4、8、10、11、14、18 和 21 对α-葡萄糖苷酶的抑制作用更为优越,抑制范围为(IC = 0.53 ± 0.01-1.36 ± 0.04 μM)。化合物 10(IC = 0.53 ± 0.01 μM)是该库中最有效的抑制剂,与标准相比,其活性增强了多倍。对合成化合物进行了分子对接,以验证配体与酶活性位点的结合相互作用。本研究确定了一些潜在的α-葡萄糖苷酶抑制剂,可用于进一步研究,以确定对抗糖尿病的有效治疗剂。

相似文献

1
Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.吲哚丙烯腈作为有潜力的抗高血糖药物:合成、α-葡萄糖苷酶抑制活性和分子对接研究。
Bioorg Med Chem. 2020 Nov 1;28(21):115605. doi: 10.1016/j.bmc.2020.115605. Epub 2020 Aug 15.
2
Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.新型吡唑并三嗪嘧啶杂合体的设计、合成、分子模拟、ADME 预测及作为潜在α-葡萄糖苷酶抑制剂的抗高血糖活性评价。
Bioorg Chem. 2019 Dec;93:103307. doi: 10.1016/j.bioorg.2019.103307. Epub 2019 Sep 20.
3
Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.合成杂环候选物作为有前途的α-葡萄糖苷酶抑制剂:概述。
Eur J Med Chem. 2019 Aug 15;176:343-377. doi: 10.1016/j.ejmech.2019.04.025. Epub 2019 Apr 30.
4
Synthesis and studies of thiazolidinedione-isatin hybrids as α-glucosidase inhibitors for management of diabetes.噻唑烷二酮-靛红杂合体的合成及作为糖尿病治疗的α-葡萄糖苷酶抑制剂的研究。
Future Med Chem. 2021 Mar;13(5):457-485. doi: 10.4155/fmc-2020-0022. Epub 2021 Jan 28.
5
Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.将吖啶连接到硫代乙酰胺上作为治疗 2 型糖尿病的新型药物的设计、合成、对接研究、α-葡萄糖苷酶抑制作用和细胞毒性活性。
Bioorg Chem. 2018 Oct;80:288-295. doi: 10.1016/j.bioorg.2018.06.035. Epub 2018 Jun 30.
6
Dithiocarbamate derivatives inhibit α-glucosidase through an apparent allosteric site on the enzyme.二硫代氨基甲酸盐衍生物通过酶上一个明显的别构位点抑制α-葡萄糖苷酶。
Chem Biol Drug Des. 2021 Aug;98(2):283-294. doi: 10.1111/cbdd.13897. Epub 2021 Jun 19.
7
Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.评价和对接吲哚磺酰胺作为链脲佐菌素诱导的糖尿病白化 Wistar 大鼠α-葡萄糖苷酶抑制剂的潜力。
Bioorg Chem. 2021 May;110:104808. doi: 10.1016/j.bioorg.2021.104808. Epub 2021 Mar 10.
8
Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.新型具有降血糖活性的α-葡萄糖苷酶抑制剂2-酰基苯并呋喃的合成及生物学评价
Chem Biol Drug Des. 2017 Dec;90(6):1184-1189. doi: 10.1111/cbdd.13038. Epub 2017 Jul 3.
9
Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.新型四氢苯并[b]噻吩-2-基)脲衍生物作为新型α-葡萄糖苷酶抑制剂的研究:合成、动力学研究、分子对接及体内降血糖活性评价。
Bioorg Chem. 2021 Oct;115:105236. doi: 10.1016/j.bioorg.2021.105236. Epub 2021 Aug 8.
10
Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus.含恶二唑环的三吲哚杂化支架的合成、α-葡萄糖苷酶抑制活性及计算机模拟研究:作为治疗II型糖尿病的潜在先导化合物
Bioorg Chem. 2017 Oct;74:30-40. doi: 10.1016/j.bioorg.2017.07.009. Epub 2017 Jul 18.

引用本文的文献

1
Computational screening for novel -glucosidase inhibitory peptides from adductor muscle as a potential antidiabetic agent.从闭壳肌中筛选新型α-葡萄糖苷酶抑制肽作为潜在抗糖尿病药物的计算筛选。
Front Nutr. 2025 Mar 24;12:1566107. doi: 10.3389/fnut.2025.1566107. eCollection 2025.
2
Quinoline-thiosemicarbazone-1,2,3-triazole-acetamide derivatives as new potent α-glucosidase inhibitors.喹啉-硫代半卡巴腙-1,2,3-三唑-乙酰胺衍生物作为新型强效α-葡萄糖苷酶抑制剂
Sci Rep. 2024 Dec 28;14(1):30876. doi: 10.1038/s41598-024-81668-5.
3
Exploration of leads from bis-indole based triazine derivatives targeting human aldose reductase in diabetic type 2: in-silico approaches.
基于双吲哚的三嗪衍生物作为2型糖尿病中人类醛糖还原酶靶点的先导化合物探索:计算机模拟方法
3 Biotech. 2025 Jan;15(1):5. doi: 10.1007/s13205-024-04178-1. Epub 2024 Dec 11.
4
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery-An Updated Review on Their Multifaceted Therapeutic Applications (2020-2024).吲哚衍生物:现代药物发现中的多功能支架-其多方面治疗应用的最新综述(2020-2024 年)。
Molecules. 2024 Oct 9;29(19):4770. doi: 10.3390/molecules29194770.
5
Potent α-glucosidase inhibitors with benzimidazole-propionitrile hybridization; synthesis, bioassay and docking study.具有苯并咪唑-丙腈杂化结构的强效α-葡萄糖苷酶抑制剂;合成、生物活性测定及对接研究。
Future Med Chem. 2024;16(22):2395-2410. doi: 10.1080/17568919.2024.2401314. Epub 2024 Oct 11.
6
Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents.N-苯乙酰基-1,2,3-三唑-吲哚-2-甲酰胺衍生物的设计、合成、体外和计算机抗α-葡萄糖苷酶活性评价及其作为新型抗糖尿病药物的研究。
Sci Rep. 2024 Jul 9;14(1):15791. doi: 10.1038/s41598-024-66201-y.
7
Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications.吲哚衍生海洋天然产物的研究现状:合成方法与治疗应用。
Mar Drugs. 2024 Mar 6;22(3):126. doi: 10.3390/md22030126.
8
Indole-Acrylonitrile Derivatives as Potential Antitumor and Antimicrobial Agents-Synthesis, In Vitro and In Silico Studies.吲哚 - 丙烯腈衍生物作为潜在的抗肿瘤和抗菌剂——合成、体外及计算机模拟研究
Pharmaceuticals (Basel). 2023 Jun 22;16(7):918. doi: 10.3390/ph16070918.
9
New NADPH Oxidase 2 Inhibitors Display Potent Activity against Oxidative Stress by Targeting p22-p47 Interactions.新型NADPH氧化酶2抑制剂通过靶向p22 - p47相互作用对氧化应激显示出强大活性。
Antioxidants (Basel). 2023 Jul 18;12(7):1441. doi: 10.3390/antiox12071441.
10
Chemistry of 3-cyanoacetyl indoles: synthesis, reactions and applications: a recent update.3-氰基乙酰基吲哚的化学:合成、反应及应用:最新进展
RSC Adv. 2023 Jul 19;13(31):21710-21745. doi: 10.1039/d3ra04385a. eCollection 2023 Jul 12.